In Vivo Protein Interactions and Complex Formation in the Pectobacterium atrosepticum Subtype I-F CRISPR/Cas System
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their associated proteins (Cas; CRISPR associated) are a bacterial defense mechanism against extra-chromosomal elements. CRISPR/Cas systems are distinct from other known defense mechanisms insofar as they provide acquired and heritable immunity. Resistance is accomplished in multiple stages in which the Cas proteins provide the enzymatic machinery. Importantly, subtype-specific proteins have been shown to form complexes in combination with small RNAs, which enable sequence-specific targeting of foreign nucleic acids. We used Pectobacterium atrosepticum, a plant pathogen that causes soft-rot and blackleg disease in potato, to investigate protein-protein interactions and complex formation in the subtype I-F CRISPR/Cas system. The P. atrosepticum CRISPR/Cas system encodes six proteins: Cas1, Cas3, and the four subtype specific proteins Csy1, Csy2, Csy3 and Cas6f (Csy4). Using co-purification followed by mass spectrometry as well as directed co-immunoprecipitation we have demonstrated complex formation by the Csy1-3 and Cas6f proteins, and determined details about the architecture of that complex. Cas3 was also shown to co-purify all four subtype-specific proteins, consistent with its role in targeting. Furthermore, our results show that the subtype I-F Cas1 and Cas3 (a Cas2-Cas3 hybrid) proteins interact, suggesting a protein complex for adaptation and a role for subtype I-F Cas3 proteins in both the adaptation and interference steps of the CRISPR/Cas mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851 · cited 1×
“The functional mechanism of CRISPR/Cas consists of three stages: 1) acquisition of resistance, 2) CRISPR RNA biogenesis and 3) interference [15].”
BackgroundMakarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I., & Koonin, E. V. (2006) · Biology Direct · doi:10.1186/1745-6150-1-7 · Cited by 1,199
RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex
Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., Terns, R. M., & Terns, M. P. (2009) · Cell · doi:10.1016/j.cell.2009.07.040 · Cited by 1,031 · cited 5×
“The formation of a complex of subtype-specific proteins has been observed across different types of CRISPR/Cas systems and plays a key role in interference [10,11,28,29,33].”
BackgroundInfluential
Cited by
The next generation of CRISPR–Cas technologies and applications
Pickar-Oliver, A., & Gersbach, C. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0131-5 · Cited by 1,459
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
Wright, A. V., Nuñez, J. K., & Doudna, J. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.035 · Cited by 989
Unravelling the structural and mechanistic basis of CRISPR–Cas systems
van der Oost, J., Westra, E. R., Jackson, R. N., & Wiedenheft, B. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3279 · Cited by 714
Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity
Nuñez, J. K., Kranzusch, P. J., Noeske, J., Wright, A. V., Davies, C. W., & Doudna, J. A. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2820 · Cited by 458
Annotation and Classification of CRISPR-Cas Systems
Makarova, K. S., & Koonin, E. V. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2687-9_4 · Cited by 437
CRISPR-Cas: Adapting to change
Jackson, S. A., McKenzie, R. E., Fagerlund, R. D., Kieper, S. N., Fineran, P. C., & Brouns, S. J. J. (2017) · Science · doi:10.1126/science.aal5056 · Cited by 394
Self-citationProtospacer recognition motifs: Mixed identities and functional diversity
Shah, S. A., Erdmann, S., Mojica, F. J. M., & Garrett, R. A. (2013) · RNA Biology · doi:10.4161/rna.23764 · Cited by 341
Vercoe, R. B., Chang, J. T., Dy, R. L., Taylor, C., Gristwood, T., Clulow, J. S., Richter, C., Przybilski, R., Pitman, A. R., & Fineran, P. C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003454 · Cited by 341
Self-citationCRISPR–Cas systems: beyond adaptive immunity
Westra, E. R., Buckling, A., & Fineran, P. C. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3241 · Cited by 323
Self-citationCRISPRTarget: Bioinformatic prediction and analysis of crRNA targets
Biswas, A., Gagnon, J. N., Brouns, S. J. J., Fineran, P. C., & Brown, C. M. (2013) · RNA Biology · doi:10.4161/rna.24046 · Cited by 318
Self-citationInactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species
Pawluk, A., Staals, R. H. J., Taylor, C., Watson, B. N. J., Saha, S., Fineran, P. C., Maxwell, K. L., & Davidson, A. R. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.85 · Cited by 311
Self-citationRemarkable Mechanisms in Microbes to Resist Phage Infections
Dy, R. L., Richter, C., Salmond, G. P. C., & Fineran, P. C. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085500 · Cited by 288
Self-citationMemory of viral infections by CRISPR-Cas adaptive immune systems: Acquisition of new information
Fineran, P. C., & Charpentier, E. (2012) · Virology · doi:10.1016/j.virol.2012.10.003 · Cited by 259
Self-citationAdaptation in CRISPR-Cas Systems
Sternberg, S. H., Richter, H., Charpentier, E., & Qimron, U. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.030 · Cited by 253
Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System
Redding, S., Sternberg, S. H., Marshall, M., Gibb, B., Bhat, P., Guegler, C. K., Wiedenheft, B., Doudna, J. A., & Greene, E. C. (2015) · Cell · doi:10.1016/j.cell.2015.10.003 · Cited by 198
Metadata
- Authors
- Richter, C., Gristwood, T., Clulow, J. S., & Fineran, P. C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-03
- Volume
- 7
- Issue
- 12
- Pages
- e49549
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2064425325
- Cited by
- 72
- References
- 3
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.